WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

N NERVOUS SYSTEM
N05 PSYCHOLEPTICS

The group is divided into therapeutic subgroups:

N05A - Antipsychotics
N05B - Anxiolytics
N05C - Hypnotics and sedatives


N05B ANXIOLYTICS

This group comprises preparations used in the treatment of neuroses and psychosomatic disorders associated with anxiety and tension, e.g. benzodiazepines.

See also:
N05A - Antipsychotics
N05C - Hypnotics and sedatives

Usually the presence of an anxiolytic (or other psycholeptics) in combined preparations must be regarded as being of secondary importance and the preparations should be classified in the respective therapeutic groups (e.g. A03C - Antispasmodics in combination with psycholeptics, N02 - Analgesics).

Combined preparations used mainly for the treatment of anxiety are classified at separate 5th levels using the corresponding 50-series.

The group is subdivided according to chemical structure.

The DDDs are based on the treatment of anxiety.


N05BE Azaspirodecanedione derivatives

    ATC code  Name  DDD  U Adm.R Note
    N05BE01 buspirone 30 mg 

List of abbreviations

Last updated: 2016-12-20